CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,450,000 | $8,320,500 | 1.17% |
| BVF INC/IL | 6,595,801 | $8,508,583 | 0.23% |
| Bronte Capital Management Pty Ltd. | 925,245 | $1,193,566 | 0.12% |
| Formidable Asset Management, LLC | 318,111 | $410,363 | 0.09% |
| Congress Park Capital LLC | 112,450 | $145,061 | 0.08% |
| Forefront Analytics, LLC | 49,421 | $63,754 | 0.04% |
| Ground Swell Capital, LLC | 10,966 | $14,146 | 0.02% |
| Clearline Capital LP | 196,583 | $253,592 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 81,352 | $104,944 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 2,646,190 | $3,412 | 0.01% |